<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942133</url>
  </required_header>
  <id_info>
    <org_study_id>CXL1</org_study_id>
    <nct_id>NCT03942133</nct_id>
  </id_info>
  <brief_title>Tow Techniques of Adductor Canal Block for Analgesia After Total Knee Replacement</brief_title>
  <official_title>Ultrasound-guided Continuous Adductor Canal Block for Analgesia After Total Knee Replacement: Comparison of Block at the Entrance and Middle of the Canal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the tow technique of continues adductor canal block for total knee
      replacement surgery. Half participants will receive catheterization at the entrance of the
      adductor canal, while the other half will receive catheterization at the middle point of the
      adductor canal.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 11, 2019</start_date>
  <completion_date type="Actual">December 16, 2019</completion_date>
  <primary_completion_date type="Actual">December 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cumulative sulfentanil consumption at 24 hours after surgery</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the strength of quadriceps femoris</measure>
    <time_frame>0,2,4,8,24,48 hours postoperatively</time_frame>
    <description>Quadriceps strength was assessed on a 0-5 scale as per the Medical Research Council Scale quadriceps motor strength(0 = no voluntary contraction possible, 1 = muscle flicker, but no movement of limb, 2 = active movement only with gravity eliminated, 3 = movement against gravity but without resistance, 4 = movement possible against some resistance and 5 = normal motor strength against resistance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The pain scores at rest determined by the numeric rating scale (NRS, 0-10)</measure>
    <time_frame>at 0,2,4,8,24,48 hours postoperatively</time_frame>
    <description>11-point numerical rating scale (NRS; 0, no pain; 10, maximum pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The pain scores on adduction of the keen determined by the numeric rating scale (NRS, 0-10)</measure>
    <time_frame>at 0,2,4,8,24,48 hours postoperatively</time_frame>
    <description>11-point numerical rating scale (NRS; 0, no pain; 10, maximum pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative nausea and vomiting (PONV)</measure>
    <time_frame>within 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with anesthesia</measure>
    <time_frame>within 5th day after surgery</time_frame>
    <description>Patient satisfaction with anesthesia was assessed using a 5-point scale (5, very satisfied; 4, satisfied; 3, neither satisfied nor dissatisfied; 2, dissatisfied; 1, very dissatisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>within 3days after surgery</time_frame>
    <description>Record complications including catheter dislodgment, puncture point infection, leakage,falling down,et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative sulfentanil consumption at other time points after surgery</measure>
    <time_frame>2,4,8,48 hours postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Analgesia</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>entrance placement of adductor canal catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>middle point placement of adductor canal catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound-guided short-axis placement of catheter at the entrance of the adductor canal</intervention_name>
    <description>Ultrasound probe is placed at the entrance of the adductor canal in short axis ï¼Œinsertion of a PAJUNK Contiplex S catheter with the tip of the catheter located at the entrance of the canal</description>
    <arm_group_label>entrance placement of adductor canal catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound-guided long-axis placement of catheter at the middle of the adductor canal</intervention_name>
    <description>Ultrasound probe is placed at the middle of the adductor canal in long axis with the caphelad end of the probe aligned with the entrance of the canal. insertion of a PAJUNK Contiplex S catheter with the tip of the catheter located at the middle of the canal</description>
    <arm_group_label>middle point placement of adductor canal catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 years

          -  Knee-arthroscopy

          -  Written consent

          -  ASA I-III

          -  BMI 19-35

        Exclusion Criteria:

          -  Unable to communicate with the investigators (e.g., a language barrier or a
             neuropsychiatric disorder).

          -  coagulopathy or on anticoagulant medication

          -  Allergic reactions toward drugs used in the trial

          -  History of substance abuse

          -  Infection at injection site

          -  Can not be mobilised to 5 meters of walk pre-surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>December 29, 2019</last_update_submitted>
  <last_update_submitted_qc>December 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Cui Xulei</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <keyword>adductor canal block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

